The Health Care System as Champion to Curb the Drug Overdose Crisis

US Department of Health and Human Services, Strategy to Combat Opioid Abuse, Misuse, and Overdose, available at <https://www.hhs.gov/opioids/sites/default/files/2018-09/opioid-fivepoint-strategy-20180917-508compliant.pdf> (last visited September 1, 2020).

Substance Abuse and Mental Health Administration, Treatment of Stimulant Use Didorders. PEP20-06-001 (June 2020), available at <https://store.samhsa.gov/product/Treatment-of-Stimulant-Use-Disorder/PEP20-06-01-001> (last visited October 30, 2020).

Centers for Disease Control and Prevention, CDC Newsroom, New Data Show Significant Changes in Drug Overdose Death, available at <https://www.cdc.gov/media/releases/2020/p0318-data-show-changes-overdose-deaths.html> (last visited September 1, 2020).

National Institute on Drug Abuse, The Science of Drug Use and Addiction: The Basics, available at <https://www.drugabuse.gov/publications/media-guide/science-drug-use-addiction-basics> (last visited September 10, 2020).

F. R. Udwadia and J. Illes , “An Ethicolegal Analysis of Involuntary Treatment for Opioid Use Disorders,” Journal of Law, Medicine & Ethics 48, no. 4 (2020): 735-740.

National Institute on Drug Abuse, Drugs, Brains, and Behavior: The Science of Addiction. 20-DA-5605 (last revised June 2020), available at <https://www.drugabuse.gov/sites/default/files/soa.pdf> (last visited October 30, 2020).

N. Volkow , “Addressing the Stigma that Surrounds Addiction,” available at <https://www.drugabuse.gov/about-nida/norasblog/2020/04/addressing-stigma-surrounds-addiction> (Last visited September 10, 2020).

L. A. Phillips and A Shaw , “Substance Use More Stigmatized than Smoking and Obesity,” Journal of Substance Use 18, no. 4 (2013): 247-253.

J.F. Kelly , R. Saitz , and S. Wakeman “Language, Substance use Disorders, and Policy: The Need to Reach Consensus on an ‘Addiction-ary,’” Alcoholism Treatment Quarterly 34, no. 1 (2016): 116-123.

S.E. Wakeman and M. L. Barnett , “Primary Care and the Opioid-Overdose Crisis — Buprenorphine Myths and Realities,” New England Journal of Medicine 379, no. 1 (2018): 1-4.

Id.

J. F. Kelly , S. E. Wakeman , and R. Saitz , “Stop Talking ‘Dirty’: Clinicians, Language, and Quality of Care for the Leading Cause of Preventable Death in the United States,” American Journal of Medicine 128, no. 1 (2015): 8-9.

H. Cooper et al., “When Prescribing Isn’t Enough — Pharmacy-Level Barriers to Buprenorphine Access,” New England Journal of Medicine 383, no. 8 (2020): 703-705.

E. Nadelmann and L. LaSalle , “Two Steps Forward, One Step Back: Current Harm Reduction Policy and Politics in the United States,” Harm Reduction Journal 14, no. 37 (2017): 37.

Harm Reduction Coalition, “Principles of Harm Reduction,” available at <https://harmreduction.org/about-us/principles-of-harm-reduction/> (last visited September 1, 2020).

Id.

Penn LDI , “Expanding Access to Naloxone: A Review of Distribution Strategies, available at <https://ldi.upenn.edu/brief/expanding-access-naloxone-review-distribution-strategies> (last visited September 1, 2020).

K. E. Vowles , M. L. McEntee , P. S. Julnes , T. Frohe , J. P. Ney , and D. N. van der Goes , “Rates of Opioid Misuse, Abuse, and Addiction in Chronic Pain: A Systematic Review and Data Synthesis,” Pain 156, no. 4 (2015): 569-576.

C. McClellan , B. H. Lambdin , M. M. Ali , R. Mutter , et al., “Opioid-Overdose Laws Asociation with Opioid Use and Overdose Mortality,” Addictive Behaviors 86 (2018): 90–95.

Evans, et al., supra note 5; Udwadia and Illes, supra note 5; A. Jain , P. Christopher , and P. Appelbaum , “Civil Commitment for Opioid and Other Substance Use Disorders: Does it Work?” Psychiatric Services 69, no. 4 (2018): 374-376.

K. Orgera and J. Tolbert , “The Opioid Epidemic and Medicaid’s Role in Facilitating Fccess to Treatment,” available at <https://www.kff.org/medicaid/issue-brief/the-opioid-epidemic-and-medicaids-role-in-facilitating-access-to-treatment/> (last visited September 1, 2020).

M.K. Mohlman et al., “Impact of Medication-Assisted Treatment for Opioid Addiction on Medicaid Expenditures and Health Services Utilization Rates in Vermont,” Journal of Substance Abuse Treatment 67 (2016): 9-14.

Substance Abuse and Mental Health Administration, supra note 2; D.A. Gorelick , “Treatment of Cannabis Use Disorder in Adults,” UpToDate, July 2020, available at <https://www.uptodate.com/contents/treatment-of-cannabis-use-disorder-in-adults?search=treatment%20of%20cannabis%20use%20disorder&source=search_result&selectedTitle=1~69&usage_type=default&display_rank=1> (last visited October 30, 2020).

L. M. Gunne and L. Gronbladh , “The Swedish Methadone Maintenance Program: A Controlled Study,” Drug and Alcohol Dependency 7, no. 3 (1981): 249-256.

Substance Abuse and Mental Health Services Administration, Key Substance use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health, available at <https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR1PDFW090120.pdf> (last visited October 30, 2020).

National Academies of Sciences, Engineering, and Medicine, Medications for Opioid Use Disorder Save Lives (Washington, DC: The National Academies Press, 2019): doi: 10.17226/25310.

21 U.S.C. § 823(g) (2020); Tenn. Code Ann. § 53-11-311 (2020).

21 U.S.C. § 823(g) (2020).

National Institute on Drug Abuse, “Understanding Drug Use and Addiction Drug Facts,” available at <https://www.drugabuse.gov/publications/drugfacts/understanding-drug-use-addiction> (last visited on September 10, 2020).

Report of the Global Commission on Drug Policy, “War on Drugs” (June 2011), available at <https://www.globalcommissionondrugs.org/wp-content/themes/gcdp_v1/pdf/Global_Commission_Report_English.pdf> (last visited September 9, 2020).

National Institute on Drug Abuse, supra note 30; Report of the Global Commission on Drug Policy, supra note 31; Drug Policy Alliance, “A Brief History of the Drug War,” available at <https://www.drugpolicy.org/issues/brief-history-drug-war> (last visited September 1, 2020).

E. Nadelmann and L. LaSalle, supra note 14; National Judicial Opioid Task Force, “Convening, Collaborating, Connecting: Courts as Leaders in the Crisis of Addiction,” available at <https://www.ncsc.org/__data/assets/pdf_file/0018/15840/njotf_final_report_111819.pdf> (last visited September 10, 2020).